Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionNontraumatic Intracerebral Hemorrhage (ICH) is the second most prevalent type of stroke worldwide and is strongly linked with severe disability and mortality. x) from 2016‐2019 using the Nationwide Readmission Database (NRD).

Hemorrhage 40

Hemorrhage Risk Factors Coronary Artery Disease Obesity 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP256-ATP256, February 1, 2024. Background:While predictors of seizure in aneurysmal subarachnoid hemorrhage (aSAH) patients have been explored, predictors for seizure in patients with angiogram-negative non-perimesencephalic SAH (an-NPSAH) are less understood. per grade increase, 95% CI 1.05-1.49;

Aneurysm 40

Aneurysm Hemorrhage Academic Hospital 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATMP78-ATMP78, February 1, 2024. Results:Among 10,652 ICH patients (median age [IQR]: 70 [58 - 80] years; 47.7% female; 43.2% lobar ICH), 3.3%, 3.1%, 0.5%, and 8.1%, respectively, experienced r-ICH, AIS, AMI, and MACE. Results:Among 10,652 ICH patients (median age [IQR]: 70 [58 - 80] years; 47.7%

Hemorrhage 40

Hemorrhage Myocardial Infarction Atrial Fibrillation Medicare 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP139-AWP139, February 1, 2024. Background:Cerebral vasospasm is a well-known complication after aneurysmal subarachnoid hemorrhage (aSAH) and occurs more commonly in younger patients. Vasospasm was defined based on transcranial Doppler (TCD) criteria.

Atherosclerosis 40

Atherosclerosis Aneurysm Hemorrhage Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP256-AWP256, February 1, 2024. Background:Assessing the economic impact of stroke and the potential for prevention through policy and programs raises questions about progress and underscores the importance of state-level data for targeted public health resource allocation. P<0.05

Stroke 40

Stroke Strokes Inpatient Public Health 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP55-AWMP55, February 1, 2024. Introduction:There has been limited study of outcomes among surrogate decision makers who make decisions on life-sustaining treatments after severe stroke. Patient characteristics were mean age: 74.6, Female: 51.8%, Mean NIHSS: 14.7, deceased at 3 months: 53.1%.

Stroke 40

Stroke Strokes Hemorrhage Outcomes 40

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundAn increased risk of recurrent stroke is noted in patients with atrial fibrillation despite direct oral anticoagulant (DOAC) use. A total of 84 patients experienced recurrent ischemic stroke after switching to different oral anticoagulants, with a total follow‐up time of 14 years. 0.39] for apixaban, 0.23 [95% CI, 0.14–0.37]

Atrial Fibrillation 75

Atrial Fibrillation Hemorrhage Pharmacology Stroke 75

Stroke Journal

JANUARY 12, 2024

Stroke, Ahead of Print. Background:Patients with severe stroke often rely on surrogate decision-makers for life-sustaining treatment decisions. Further study of outcomes among diverse populations of stroke surrogate decision-makers may help to identify sources of strength and resiliency that may be broadly applicable.

Stroke 40

Stroke Strokes Hemorrhage Outcomes 40

Stroke Journal

OCTOBER 30, 2023

Stroke, Volume 54, Issue 12 , Page 3038-3045, December 1, 2023. We conducted a time-stratified case-crossover study among 86 635 emergency hospital admissions for stroke across 10 hospitals in 3 cities (Jinhua, Hangzhou, and Zhoushan) in Zhejiang province, China, between January 1, 2016 and December 31, 2021.

Hospital 40

Hospital Stroke Strokes Public Health 40

Stroke Journal

MARCH 21, 2024

Stroke, Ahead of Print. There is growing interest in incorporating PROMs into clinical trials, but the extent that such measures are used in contemporary stroke trials is uncertain. Eligible studies were phase 2 or 3 trials that tested therapeutic interventions within 1 month of stroke onset.

Stroke 40

Stroke Strokes Outcomes Quality of Life 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionOptimal triage strategies for patients suspected of acute ischemic stroke due to large vessel occlusion remains debated. Outcomes were compared for EVT hospitalizations with direct vs transferred presentation at discharge.

Hospital 40

Hospital Outcomes Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP123-ATP123, February 1, 2024. Background:Hospitals with higher procedure volume are more likely to have lower rates of death or disability, with most neurovascular surgical and endovascular procedures.

Hospital 40

Hospital Stroke Strokes Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. We aimed to investigate the safety of intravenous tissue plasminogen activator (IV tPA) and mechanical thrombectomy (MT) for acute ischemic stroke (AIS), and compare the functional outcome in cardiomyopathy patients with and without HF.

Heart Failure 40

Heart Failure Cardiomyopathy Inpatient Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP155-AWP155, February 1, 2024. Methods:We conducted a retrospective cohort study using US data from the National Inpatient Sample (NIS) for the years 2016 to 2019. 10.7%) had an ischemic stroke, 1,685 (4.3%; 95% CI, 3.8-4.7%) Among patients with PRES, 3,950 (10.0%; 95% CI, 9.4-10.7%)

Inpatient 40

Inpatient Hemorrhage Hospital Stroke 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP5-ATP5, February 1, 2024. Data from 9 centers in the United States, Europe, and Asia for IA patients who undertook endovascular treatment (EVT) or microsurgical treatment (MST) between January 2016 and December 2020 were included for analysis. The primary outcome was 90-day mRS 0-2.

Aneurysm 40

Aneurysm Outcomes Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP148-AWP148, February 1, 2024. Background:The recognition of in-hospital strokes (IHS) and their subsequent interventions remain challenging. IHS do not have guideline-based efficiency metrics established. Only 1 in 5 IHS receive treatment within 60 minutes of symptom recognition time (SRT).

Hospital 40

Hospital Nursing Hemorrhage Stroke 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. We aimed to investigate the impact of COVID‐19 on the overall complications, including ischemic stroke and subarachnoid hemorrhage (SAH) rates in patients treated for intracranial aneurysms (IAs).MethodsThis vs. 28.3%; p<0.001).

COVID-19 40

COVID-19 Aneurysm Outcomes Inpatient 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWMP7-AWMP7, February 1, 2024. Background:Despite decades long adoption as the standard-of-care for ischemic stroke, the majority of eligible patients do not receive intravenous thrombolysis (IVT), with underutilization especially pronounced in rural areas.

Thrombolysis 40

Thrombolysis Stroke Strokes Education 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A134-A134, February 1, 2024. In severe OHSS, increases in capillary permeability can result in hemoconcentration and hypercoagulability leading to thrombotic events, including stroke and cerebral venous thrombosis. were included from each dataset. were included from each dataset.

Thrombosis 40

Thrombosis Inpatient Embolism Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Further investigation may help delineate how these predictors can be utilized to inform clinical decisions and discussions regarding stroke patients receiving mechanical thrombectomy.

Outcomes 40

Outcomes Stroke Strokes Hemorrhage 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP244-ATP244, February 1, 2024. Racial and ethnic disparities in risk factors and outcomes for young patients with ischemic stroke (AIS) are well described.

Risk Factors 40

Risk Factors Hemorrhage Outcomes Inpatient 40

Stroke: Vascular and Interventional Neurology

FEBRUARY 26, 2024

Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDWomen are underrepresented in stroke thrombectomy trials, and the impact of sex differences in outcomes after stroke thrombectomy is unclear. and symptomatic intracranial hemorrhage (OR = 1.00, 95% CI = 0.44–2.26) 2.26) in the cohort study by sex.

Stroke 40

Stroke Strokes Outcomes Hemorrhage 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page A60-A60, February 1, 2024. Background:Given the paucity of high-quality data on acute stroke therapies in patients with pre-morbid disability, they risk being routinely excluded from such therapies. Pre-morbid disability was defined as pre-stroke modified Rankin Scale score (mRS) >2.

Stroke 40

Stroke Strokes Outcomes Hemorrhage 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP173-AWP173, February 1, 2024. Background:We identified that major ABO incompatible platelet transfusions are associated with poor intracerebral hemorrhage (ICH) outcomes, yet the driver for this relationship is unknown and does not appear to be related to impaired hemostasis.

Hemorrhage 40

Hemorrhage Risk Factors Ischemia Outcomes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIt is controversial when to pursue carotid artery stenting (CAS) after acute tandem occlusion (TO) strokes treated with endovascular thrombectomy (EVT). CAS performed on day ‐1, 0 or 1 day after admission was considered as emergent CAS.

Stents 40

Stents Stent Stroke Strokes 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP171-AWP171, February 1, 2024.

Risk Factors 40

Risk Factors Hemorrhage Outcomes Blood Pressure 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP123-AWP123, February 1, 2024. Background:Cisternal score (CISCO), which is calculated based on quantification of blood clot in basal cisterns, has been shown to have good accuracy in predicting ventriculoperitoneal shunt requirement in patients with aneurysmal subarachnoid hemorrhage (aSAH).

Blood Clot 40

Blood Clot Aneurysm Hemorrhage Academic 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP286-AWP286, February 1, 2024. Introduction:Cerebral amyloid angiopathy (CAA) is associated with multiple conditions that are known to have an elevated risk of seizures, including intracerebral hemorrhage, CAA-related inflammation, and Alzheimer’s disease.

Medicare 40

Medicare Outpatient Inpatient Hemorrhage 40

SoftCath

JUNE 20, 2021

In the neuroimaging field, AI applications are being used to develop triage mechanisms that can detect brain hemorrhage in a patient at an inceptive level. Also, the technology helps in stroke detection by enabling the software to find large vessel occlusions that can further cause a stroke.

Technology 52

Technology Cancer COVID-19 Blood Clot 52

Dr. Smith's ECG Blog

APRIL 8, 2015

Also consider non-hemorrhagic volume depletion, dehydration : orthostatic vitals may uncover this [see Mendu et al. (3)]. Finally, much of this correlates well with The new Canadian Syncope Arrhythmia Risk Score , just published in 2016, results of which are given below in the Annotated Bibliography. to 3.80). of ED visits.

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52